P. aeruginosa virulence in cystic fibrosis lung disease

囊性纤维化肺病中铜绿假单胞菌的毒力

基本信息

  • 批准号:
    6816543
  • 负责人:
  • 金额:
    $ 12.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-15 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal describes a 5 year training program for development of a career in translational research in pulmonary medicine. The proposed program integrates clinical research in cystic fibrosis (CF) with functional genomics. As mentor, Dr. Stephen Lory, an expert in P. aeruginosa biology, will supervise aspects of P. aeruginosa genetic analysis. As co-mentor, Dr. Mary Ellen Wohl, an expert in CF clinical research, will supervise aspects involving clinical research design. As co-mentor, Dr. Gerald Pier, an expert in host-pathogen interactions in CF, will supervise aspects involving data analysis and applications to the host response. Infection with P. aeruginosa has been associated with decline in pulmonary function in CF. The P. aeruginosa microarray provides the means to undertake a comprehensive analysis of expression of all potential virulence factors encoded in the P. aeruginosa genome. The goal of the proposed research is to use a functional genomics approach to identify virulence factors associated with progression of CF lung disease. Our preliminary data show that we can characterize gene expression in clinical P. aeruginosa CF isolates by high throughput transcriptional profiling, and that older CF subjects are colonized with attenuated strains that have undergone deletions of several key virulence factors. We hypothesize that severity of CF lung disease is related to differential expression of specific P. aeruginosa virulence factors. We will address our hypothesis with the following aims: 1) to identify P. aeruginosa virulence factors expressed during different stages of lung disease progression by microarray analysis, and 2) to confirm the association between the expression of identified P. aeruginosa genes and progression of lung disease. Initially, we will employ microarray analysis to obtain global transcriptional profiles of P. aeruginosa in subjects with different disease severity. We will confirm the findings of the microarray experiments using RT-PCR on RNA obtained from P. aeruginosa isolates and directly from sputum samples from a larger number of subjects. These experiments will provide insights into the in vitro and in vivo effects of P. aeruginosa virulence factors in CF that may be important targets for new therapies with the potential to decrease disease-specific morbidity and mortality in CF.
描述(由申请人提供): 该提案描述了一个为期5年的培训计划,用于发展肺部医学转化研究的职业生涯。该计划将囊性纤维化(CF)的临床研究与功能基因组学相结合。作为导师,铜绿假单胞菌生物学专家Stephen Lory博士将监督铜绿假单胞菌遗传分析的各个方面。作为共同导师,玛丽埃伦沃尔博士,在CF临床研究的专家,将监督涉及临床研究设计方面。作为共同导师,杰拉尔德码头,在CF宿主-病原体相互作用的专家,将监督涉及数据分析和应用到主机响应方面。 铜绿假单胞菌感染与CF的肺功能下降相关。铜绿假单胞菌微阵列提供了对铜绿假单胞菌基因组中编码的所有潜在毒力因子的表达进行全面分析的手段。这项研究的目的是使用功能基因组学方法来鉴定与CF肺病进展相关的毒力因子。我们的初步数据表明,我们可以通过高通量转录谱来表征临床铜绿假单胞菌CF分离株的基因表达,并且老年CF受试者被几个关键毒力因子缺失的减毒菌株定殖。 我们推测CF肺病的严重程度与特异性铜绿假单胞菌毒力因子的差异表达有关。我们将通过以下目的来解决我们的假设:1)通过微阵列分析来鉴定在肺部疾病进展的不同阶段表达的铜绿假单胞菌毒力因子,以及2)确认鉴定的铜绿假单胞菌基因的表达与肺部疾病进展之间的关联。最初,我们将采用微阵列分析来获得不同疾病严重程度受试者中铜绿假单胞菌的全局转录谱。我们将使用从铜绿假单胞菌分离株和直接从大量受试者的痰液样本中获得的RNA进行RT-PCR,证实微阵列实验的结果。这些实验将提供对铜绿假单胞菌毒力因子在CF中的体外和体内作用的见解,这些毒力因子可能是新疗法的重要靶点,具有降低CF中疾病特异性发病率和死亡率的潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLAUDIA ORDONEZ其他文献

CLAUDIA ORDONEZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLAUDIA ORDONEZ', 18)}}的其他基金

Phase 2 study of VX-770 in Cystic Fibrosis Subjectswith G551D
VX-770 在囊性纤维化受试者中与 G551D 的 2 期研究
  • 批准号:
    7368521
  • 财政年份:
    2007
  • 资助金额:
    $ 12.64万
  • 项目类别:
ASSESSMENT OF INDUCED SPUTUM AS A TOOL TO EVALUATE ANTI-INFLAMMATORY AGENTS
诱导痰的评估作为评估抗炎药的工具
  • 批准号:
    7380743
  • 财政年份:
    2006
  • 资助金额:
    $ 12.64万
  • 项目类别:
FORMULA FORIFIED W/ DOCOSAHEXAENOIC ACID (DHA) IN INFANTS W/ CYSTIC FIBROSIS
适用于患有囊性纤维症的婴儿的二十二碳六烯酸 (DHA) 强化配方奶粉
  • 批准号:
    7380742
  • 财政年份:
    2006
  • 资助金额:
    $ 12.64万
  • 项目类别:
USE OF SPUTUM IND TO STUDY INFECTION & INFLAM IN CHILD W/CF PHS I&II
使用痰液研究研究感染
  • 批准号:
    7204673
  • 财政年份:
    2005
  • 资助金额:
    $ 12.64万
  • 项目类别:
TISSUE BANK FOR PULMONARY DISEASES
肺部疾病组织库
  • 批准号:
    7204680
  • 财政年份:
    2005
  • 资助金额:
    $ 12.64万
  • 项目类别:
P aeruginosa virulence in cystic fibrosis lung disease
囊性纤维化肺病中铜绿假单胞菌的毒力
  • 批准号:
    7085484
  • 财政年份:
    2004
  • 资助金额:
    $ 12.64万
  • 项目类别:
Phase I trial comparing two delivery methods and doses of TOBI in CF patients
比较 CF 患者中两种 TOBI 给药方法和剂量的 I 期试验
  • 批准号:
    6975155
  • 财政年份:
    2004
  • 资助金额:
    $ 12.64万
  • 项目类别:
Cystic Fibrosis Once Daily Aminoglycoside Clinical Trial (CFODACT)
囊性纤维化每日一次氨基糖苷类临床试验 (CFODACT)
  • 批准号:
    6975140
  • 财政年份:
    2004
  • 资助金额:
    $ 12.64万
  • 项目类别:
Study of Airway Inflammation in Subjects with Cystic Fibrosis
囊性纤维化患者气道炎症的研究
  • 批准号:
    6975110
  • 财政年份:
    2004
  • 资助金额:
    $ 12.64万
  • 项目类别:
Tissue Bank for Pulmonary Diseases
肺部疾病组织库
  • 批准号:
    6975142
  • 财政年份:
    2004
  • 资助金额:
    $ 12.64万
  • 项目类别:

相似海外基金

Deciphering newly uncovered mechanisms of fluid regulation in bacterial RNA-protein networks
破译细菌 RNA-蛋白质网络中新发现的液体调节机制
  • 批准号:
    2349832
  • 财政年份:
    2024
  • 资助金额:
    $ 12.64万
  • 项目类别:
    Standard Grant
Mechanisms of bacterial RNA degradation
细菌RNA降解机制
  • 批准号:
    10406497
  • 财政年份:
    2022
  • 资助金额:
    $ 12.64万
  • 项目类别:
Mechanisms of bacterial RNA degradation
细菌RNA降解机制
  • 批准号:
    10674199
  • 财政年份:
    2022
  • 资助金额:
    $ 12.64万
  • 项目类别:
Mechanisms of bacterial RNA degradation
细菌RNA降解机制
  • 批准号:
    10621918
  • 财政年份:
    2022
  • 资助金额:
    $ 12.64万
  • 项目类别:
Mechanistic studies of a new family of bacterial RNA chaperones
细菌RNA伴侣新家族的机制研究
  • 批准号:
    RGPIN-2016-05163
  • 财政年份:
    2021
  • 资助金额:
    $ 12.64万
  • 项目类别:
    Discovery Grants Program - Individual
Mechanistic studies of a new family of bacterial RNA chaperones
细菌RNA伴侣新家族的机制研究
  • 批准号:
    RGPIN-2016-05163
  • 财政年份:
    2020
  • 资助金额:
    $ 12.64万
  • 项目类别:
    Discovery Grants Program - Individual
Development of a Novel Class of Gram-Negative Antibiotics that Target Bacterial RNA
开发一类针对细菌 RNA 的新型革兰氏阴性抗生素
  • 批准号:
    10016075
  • 财政年份:
    2019
  • 资助金额:
    $ 12.64万
  • 项目类别:
Mechanistic studies of a new family of bacterial RNA chaperones
细菌RNA伴侣新家族的机制研究
  • 批准号:
    RGPIN-2016-05163
  • 财政年份:
    2019
  • 资助金额:
    $ 12.64万
  • 项目类别:
    Discovery Grants Program - Individual
Mechanistic studies of a new family of bacterial RNA chaperones
细菌RNA伴侣新家族的机制研究
  • 批准号:
    RGPIN-2016-05163
  • 财政年份:
    2018
  • 资助金额:
    $ 12.64万
  • 项目类别:
    Discovery Grants Program - Individual
Elucidation of molecular pathogenesis in bacterial RNA-induced cytokine storm
阐明细菌 RNA 诱导的细胞因子风暴的分子发病机制
  • 批准号:
    17K10012
  • 财政年份:
    2017
  • 资助金额:
    $ 12.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了